abecmahcp.com | CAR T Cell Therapy for R/R Multiple Myeloma

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /search.html Disallow: /thank-you.html Sitemap:

Meta Tags

Title	CAR T Cell Therapy for R/R Multiple Myeloma \| ABECMA® (idecabtagene
Description	CHALLENGE ABECMA® (idecabtagene vicleucel) is the first CAR T cell therapy for adult patients with R/R multiple myeloma. See Safety Info and Boxed
Keywords	N/A

Server Information

WebSite	abecmahcp.com
Host IP	45.60.150.161
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

abecmahcp.com Valuation

US$6,476,127

Last updated: 2023-05-11 04:47:17

abecmahcp.com has Semrush global rank of 1,634,357. abecmahcp.com has an estimated worth of US$ 6,476,127, based on its estimated Ads revenue. abecmahcp.com receives approximately 747,246 unique visitors each day. Its web server is located in United States, with IP address 45.60.150.161. According to SiteAdvisor, abecmahcp.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$6,476,127
Daily Ads Revenue	US$5,978
Monthly Ads Revenue	US$179,339
Yearly Ads Revenue	US$2,152,067
Daily Unique Visitors	49,817
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
abecmahcp.com.	A	299	IP: 45.60.150.161
abecmahcp.com.	A	299	IP: 45.60.170.161
abecmahcp.com.	NS	86400	NS Record: ns-1718.awsdns-22.co.uk.
abecmahcp.com.	NS	86400	NS Record: ns-309.awsdns-38.com.
abecmahcp.com.	NS	86400	NS Record: ns-744.awsdns-29.net.
abecmahcp.com.	NS	86400	NS Record: ns-1220.awsdns-24.org.

HtmlToTextCheckTime:2023-05-11 04:47:17

This site is intended for U.S. healthcare professionals only. Indication ABECMA (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. --> Full Prescribing Information ABECMA REMS Patient Site INDICATION ABECMA (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. This site is intended for U.S. healthcare professionals only. Home Unmet Need MOA Trial Design Trial Design Patient

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Thu, 04 Nov 2021 02:22:42 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
Set-Cookie: AWSALBTG=TCqyQP3Awqwbp14Rvta2PDfwqaa141OihKd+oqPutdIhdV1rPP1zAbEPyib5dBTuXWv+Sn2lbyq71F1IdGINPdK1G+JRef46fJRMXYSDsgRxxkBJ/3MYPpCVaL4jCGpGK3gDU6aMxv193WPZP/tH/bAsoe1Rpf/kD9jKQfhp1Bv+zeYYbmk=; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBTGCORS=TCqyQP3Awqwbp14Rvta2PDfwqaa141OihKd+oqPutdIhdV1rPP1zAbEPyib5dBTuXWv+Sn2lbyq71F1IdGINPdK1G+JRef46fJRMXYSDsgRxxkBJ/3MYPpCVaL4jCGpGK3gDU6aMxv193WPZP/tH/bAsoe1Rpf/kD9jKQfhp1Bv+zeYYbmk=; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/; SameSite=None
Server: Apache
Location: https://abecmahcp.com/
Set-Cookie: AWSALBAPP-0=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBAPP-1=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBAPP-2=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBAPP-3=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: visid_incap_2613576=4ZWK5Pu8T+6LLob/mDBuGvFDg2EAAAAAQUIPAAAAAADPUFEmJwfKiaGSNJ+/5fqs; expires=Thu, 03 Nov 2022 09:46:14 GMT; HttpOnly; path=/; Domain=.abecmahcp.com
Set-Cookie: nlbi_2613576=JwzdaGeT8H/vjKtjCY4a+gAAAADkfOepm9Wy3+qn/vquPgoX; path=/; Domain=.abecmahcp.com
Set-Cookie: incap_ses_512_2613576=Dw5aHnKOnjUPVwHyy/0aB/FDg2EAAAAAqK8Z5+WVkH6rD/5BUVdpnw==; path=/; Domain=.abecmahcp.com
Set-Cookie: ___utmvmBauwPzRZ=nacLionwLvj; path=/; Max-Age=900
Set-Cookie: ___utmvaBauwPzRZ=nWvHwvL; path=/; Max-Age=900
Set-Cookie: ___utmvbBauwPzRZ=aZU
    XBxOIald: AtK; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 10-28042503-28042504 NNNN CT(23 -1 0) RT(1635992561879 0) q(0 0 1 0) r(1 1) U6

HTTP/1.1 301 Moved Permanently
Date: Thu, 04 Nov 2021 02:22:42 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
Set-Cookie: AWSALBTG=7bkxVlcA9Jvxr+l2AB97V9FznWkRz7O9xiDuNs3u0IPy63g6QRCNzjk7O91cTvxI/ooF8HoJET+z2ra0UQbGOxPlnhnHz6uUl+SVYaUNbk220WbhBr8X1ql0A5joqd76qoig9F1Lq0diNPr67NzBiRYuL/H+Nj6tg7yFe3G6nJdxo3aA8E0=; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBTGCORS=7bkxVlcA9Jvxr+l2AB97V9FznWkRz7O9xiDuNs3u0IPy63g6QRCNzjk7O91cTvxI/ooF8HoJET+z2ra0UQbGOxPlnhnHz6uUl+SVYaUNbk220WbhBr8X1ql0A5joqd76qoig9F1Lq0diNPr67NzBiRYuL/H+Nj6tg7yFe3G6nJdxo3aA8E0=; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/; SameSite=None; Secure
Server: Apache
Location: https://www.abecmahcp.com/
Set-Cookie: AWSALBAPP-0=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBAPP-1=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBAPP-2=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: AWSALBAPP-3=_remove_; Expires=Thu, 11 Nov 2021 02:22:42 GMT; Path=/
Set-Cookie: visid_incap_2613576=P3nqobIqQJKBkSHml79TDfJDg2EAAAAAQUIPAAAAAAB4C/84N2FXb9IjzEVtEcs/; expires=Thu, 03 Nov 2022 06:49:08 GMT; HttpOnly; path=/; Domain=.abecmahcp.com
Set-Cookie: nlbi_2613576=/siRCrhwDm2m5idtCY4a+gAAAAApHbBffKi8soi3wTBlT8hY; path=/; Domain=.abecmahcp.com
Set-Cookie: incap_ses_303_2613576=U5BfU+vo8j10dTBS/Hg0BPJDg2EAAAAAwMi1yycgae16ya4OmuyTVw==; path=/; Domain=.abecmahcp.com
Set-Cookie: ___utmvmawuwPzRZ=WjLfVxKLTxl; path=/; Max-Age=900
Set-Cookie: ___utmvaawuwPzRZ=PjjZPjX; path=/; Max-Age=900
Set-Cookie: ___utmvbawuwPzRZ=RZw
    XIgOealL: itC; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 12-45989163-45989187 NNNN CT(20 47 0) RT(1635992562598 39) q(0 0 1 0) r(1 1) U6

HTTP/1.1 200 OK
Date: Thu, 04 Nov 2021 02:22:43 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Set-Cookie: AWSALBTG=wwhnW1FebNvcAj/JBmzwgLC8+0/P1J2IhQi1VtFggE0tRLalkPtDLatwuCX0QEg6EsVHQfAg/ThQNTwLirGli+tNv6l1T1YmJuXo+yPVyko3TdTjmArdwSrp1mqvZe99zvargBy6bZCTmo82Uuur9bkfa65D5U3qCi1bUj8HeSAXiQ1oPHA=; Expires=Thu, 11 Nov 2021 02:22:43 GMT; Path=/
Set-Cookie: AWSALBTGCORS=wwhnW1FebNvcAj/JBmzwgLC8+0/P1J2IhQi1VtFggE0tRLalkPtDLatwuCX0QEg6EsVHQfAg/ThQNTwLirGli+tNv6l1T1YmJuXo+yPVyko3TdTjmArdwSrp1mqvZe99zvargBy6bZCTmo82Uuur9bkfa65D5U3qCi1bUj8HeSAXiQ1oPHA=; Expires=Thu, 11 Nov 2021 02:22:43 GMT; Path=/; SameSite=None; Secure
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
Link: ; rel=shortlink
Set-Cookie: PHPSESSID=db63c303e31d31a43bbc7023c2e0436c; path=/;HttpOnly;Secure
X-XSS-Protection: 1; mode=block
Set-Cookie: AWSALBAPP-0=AAAAAAAAAADSgrFeYFbiOgCXrMWNs8jn/NDzC0BiyTjNMW9ICuxsp6CCUG0NDwyelpR4THKtOoB/AtVw/TCQ17n5Br7K1623W8biIGW34mifGf8rnFYqcGUgfLGR5CtIefhAxASzBD9m4F3F/z4u9Od8tOg=; Expires=Thu, 11 Nov 2021 02:22:43 GMT; Path=/
Set-Cookie: AWSALBAPP-1=_remove_; Expires=Thu, 11 Nov 2021 02:22:43 GMT; Path=/
Set-Cookie: AWSALBAPP-2=_remove_; Expires=Thu, 11 Nov 2021 02:22:43 GMT; Path=/
Set-Cookie: AWSALBAPP-3=_remove_; Expires=Thu, 11 Nov 2021 02:22:43 GMT; Path=/
Set-Cookie: visid_incap_2613576=f9SMXeLqT96QuX985InaOvJDg2EAAAAAQUIPAAAAAAB+F7pWlP7CBoWR3Wjfn0Q2; expires=Thu, 03 Nov 2022 09:46:14 GMT; HttpOnly; path=/; Domain=.abecmahcp.com
Set-Cookie: nlbi_2613576=1Q7tQav9HGsHb/0uCY4a+gAAAADs1VV6MGBl+sgBIkOqEeQF; path=/; Domain=.abecmahcp.com
Set-Cookie: incap_ses_512_2613576=R/VZASm16nBCVwHyy/0aB/JDg2EAAAAAW7swXyfTy29ZOwb6jOQU6g==; path=/; Domain=.abecmahcp.com
Set-Cookie: ___utmvmBauwPzRZ=dtSqcUtrxLZ; path=/; Max-Age=900
Set-Cookie: ___utmvaBauwPzRZ=clcFoXZ; path=/; Max-Age=900
Set-Cookie: ___utmvbBauwPzRZ=kZD
    XLvOxala: Mtj; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 4-23679093-23679095 NNNN CT(23 44 0) RT(1635992562185 19) q(0 0 0 1) r(5 5) U6

abecmahcp.com Whois Information

Domain Name: ABECMAHCP.COM
Registry Domain ID: 2516775493_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-04-16T05:12:11Z
Creation Date: 2020-04-20T13:14:27Z
Registry Expiry Date: 2022-04-20T13:14:27Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-1220.AWSDNS-24.ORG
Name Server: NS-1718.AWSDNS-22.CO.UK
Name Server: NS-309.AWSDNS-38.COM
Name Server: NS-744.AWSDNS-29.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-10-17T06:20:37Z <<<

abecmahcp.com valuation and analysis